REFERENCES
- Strampelli B. Keratoprosthesis with osteodontal tissue. Am J Ophthalmology 1963; 89: 1029–39
- Fyodorov S N, Moroz Z I, Zuev V K. Keratoprostheses. Churchill Livingstone. 1987; 1–137
- Liu C, Tighe B. The properties of the ideal keratoprosthesis. Anales Del Instituto Barraquer (Barc.) 1999; 28(S)155–6
- Liu C, Tighe B. Striving for the perfect keratoprosthesis. British Journal of Ophthalmology 1998; 82: 3–4, [PUBMED], [INFOTRIEVE], [CSA]
- Falcinelli G C, Barogi G, Caselli M, Colliardo P, Taloni M. Personal changes and innovations in Strampelli's osteo-odonto-keratoprosthesis. Anales Del Instituto Barraquer (Barc.) 1999; 28(S)47–8, [CSA]
- Liu C, Pagliarini S. Independent survey of long term results of the Falcinelli osteo-odonto-keratoprosthesis (OOKP). Anales Del Instituto Barraquer (Barc.) 1999; 28(S)91–3, [CSA]
- De Leo D, Hickey P A, Meneghel G, Cantor C H. Blindness, Fear of Sight loss, and Suicide. Psychosomatics 1999; 40(4)339–44, [PUBMED], [INFOTRIEVE], [CSA]
- Thume L, Murphree O D. Acceptance of the white cane and hope for the restoration of sight in blind persons as an indicator of adjustment. J Clin Psychol 1961; 17: 208–9, [PUBMED], [INFOTRIEVE]
- Falcinelli G, Barogi G, Taloni M. Osteoodontokeratoprosthesis: Present experience and future prospects. Refract Corneal Surg 1993; 9: 193–4
- Caselli M, Colliardo P, Falcinelli G, Nebbioso M. Falcinelli's osteo-odonto-keratoprosthesis: Long term results. An Inst Barraquer (Barc.) 1999; 28(S)113–4
- Colliardo P, Caselli M, Falcinelli G C, Grabner G, Micozzi I. Osteo-odonto-keratoprosthesis in the treatment of corneal blindness due to “dry eye.”. An Inst Barraquer (Barc.) 2001; 30: 189–90
- Falcinelli G, Colliardo P, Corazza E, Taloni M. Falcinelli's osteo-odonto-keratoprosthesis: 25 years of surgical experience. An Inst Barraquer (Barc.) 2001; 30: 53–4
- Hille K, Landau H, Ruprecht K W. Osteo-odonto-keratoprosthesis. A summary of 6 years surgical experience. Ophthalmologe 2002; 99(2)90–5, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Liu C, Sciscio A, Smith G, Pagliarini S, Herold J. Indications and technique of modern Osteo-odonto-keratoprosthesis (OOKP) surgery. Eye News 1998; 5: 17–22, [CSA]
- Liu C, Herold J, Sciscio A, Smith G, Hull C. Osteo-odonto-keratoprosthesis surgery. Br J Ophthalmol 1999; 83: 127, [PUBMED], [INFOTRIEVE], [CSA]
- Falcinelli G C, Taloni M, Corazza E, Buratto E, Falcinelli G. Extension of indications for osteo-odonto-keratoprosthesis. An Inst. Barraquer (Barc.) 1999; 28(Suppl.)151–2, [CSA]
- Tandon R, Herold J, Thorp S, Hull C, Britain P, Goldberg L, Liu C. Results of the osteo-odonto-keratoprosthesis (OOKP) in severe inflammatory eye diseases. Experience from the United Kingdom. Proceedings of the 5th KPro-8th IOSS Joint Meeting, Miami, Florida, May, 9–102003. Anales Del Instituto Barraquer, In press
- Marchi V, Ricci R, Pecorella I, Ciardi A, Di Tondo U. Osteo-Odonto-Keratoprosthesis. Description of surgical technique with results in 85 patients. Cornea 1994; 3: 125–30
- Dohlman C H, Doane M G. Keratoprosthesis in end-stage dry eye. Adv Exp Med Biol 1994; 350: 561–4, [PUBMED], [INFOTRIEVE]
- Dohlman C H, Terada H. Keratoprosthesis in pemphigoid and Stevens-Johnson syndrome. Adv Exp Med Biol 1998; 438: 1021–5, [PUBMED], [INFOTRIEVE], [CSA]
- Legeais J M, Renard G, Pouliquen Y. A second generation of biointegrable keratoprostheses. An Inst Barraquer (Barc.) 1999; 28(S)57–8, [CSA]
- Legeais J M, Renard G. A second generation of artificial cornea with soft optical system: first human investigation. An Inst Barraquer (Barc.) 2001; 30: 101–2, [CSA]
- Lund O E. Grenzen und Moglichkeiten der optischen Keratoprothese. Ein klinischer und histopathologischer Bericht. Klin Monatsbl Augenheilkd 1982; 180: 3–12, [PUBMED], [INFOTRIEVE]
- Pintucci S, Pintucci F, Cecconi M, Caiazza S. New Dacron tissue colonizable keratoprostheis: clinical experience. Br J Ophthalmol 1995; 79: 825–9, [PUBMED], [INFOTRIEVE], [CSA]
- Pintucci S, Pintucci F, Caiazza S, Cecconi M. The Dacron felt colonizable keratoprosthesis: after 15 years. Eur J Ophthalmol 1996; 6: 125–30, [PUBMED], [INFOTRIEVE], [CSA]
- Pintucci S, Pintucci F, Caiazza S, Karcioglu Z A. Short and long term complications of the PMMA/Dacron biointegrated keratoprosthesis: 18 years of experience. Invest Ophthalmol Vis Sci 1998; 39(4)S77
- Pintucci S, Pintucci F, Cecconi M, Caiazza S. The Pintucci Dacron tissue KP: long-term results, postoperative care and revisions in dry eyes and in eyes with tear secretion. An Inst Barraquer (Barc.) 1999; 28(S)109–12
- Crawford G J, Hicks C R, Lou X, Vijayasekaran S, Tan D, Mulholland B, Chirila T V, Constable I J. The Chirila Keratoprosthesis: phase I human clinical trial. Ophthalmology 2002; 109(5)883–9, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nouri M, Terada H, Alfonso E C, et al. Endophthalmitis after keratoprosthesis; incidence, bacterial causes, and risk factors. Arch Ophthalmol 2001; 19: 484–9
- Nouri M, Terada H, Durand M L, Alfonso E, Dohlman C H. Risk factors for endophthalmitis in keratoprosthesis patients. An Inst Barraquer (Barc.) 2001; 30: 123–4
- Falcinelli G C, Falsini B, Taloni M, Piccardi R, Falcinelli G. Detection of glaucomatous damage in patients with osteo-odonto-keratoprosthesis. Brit J Ophthalmol 1995; 79: 129–34, [CSA]
- Bellelli A, Avitto A, Liberali M, Iannetti F, Iannetti L, David V. Osteo-odonto-keratoprosthesis. Radiographic, CT and MR features. Radiol Med (Torino) 2001; 102: 143–7, [CSA]
- Stoiber J, Forstner R, Csaky D, Ruckhofer J, Grabner G. Evaluation of bone reduction in osteo-odontokeratoprosthesis (OOKP) by three-dimensional computed tomography. Cornea 2003; 22: 126–30, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tandon R, Herold J, Thorp S, Hull C, Goldberg L, Georgiou T, Liu C. Tooth allografts for osteo-odontokeratoprosthesis in edentulous patients with end-stage ocular surface disease. Proceedings of the 5th KPro-8th IOSS Joint meeting, Miami, Florida, May, 9–102003. Anales Del Instituto Barraquer, In press
- Belin M W, Bouchard C S, Phillips T M. Update on topical ciclosporin A. Background, immunology, and pharmacology. Cornea 1990; 9: 184–95, [PUBMED], [INFOTRIEVE]
- Campana C, Regazzi M B, Buggia I, Molinaro M. Clinically significant drug interactions with ciclosporin. An update. Clin Pharmacokinet 1996; 30: 141–79, [PUBMED], [INFOTRIEVE], [CSA]
- Liu C S, Hull C, Herold J, Paul B, Tandon R. Functional Vision after osteo-odonto-keratoprosthesis. Our experience with different cylinder designs, ARVO abstracts 2004[CSA]
- Hull C, Liu C, Sciscio A, Eleftheriadia H, Herold J. Optical cylinder designs to increase the field of vision in the osteo-odonto-keratoprosthesis. Graefe's Archive for Clinical and Experimental Opthalmology 2000; 238: 1002–8, [CSA], [CROSSREF]
- Hille K, Landau H, Ruprecht K W. Improvement of the osteo-odonto-keratoprosthesis according to Strampelli: influence of diameter of PMMA cylinder on visual field. Graefes Arch Clin Exp Ophthalmol 1999; 237(4)308–12, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Leon C R. Hydroxyapatite Keratoprosthesis Made from Coral. Oculoplastic and Reconstructive Surgery 1997; 61–5, [CSA]
- Liu C, Green D, Hull C, Lydon F, Franklin V, Tighe B, Sandeman S, Lloyd A, Herold J. Potential advantages of a synthetic osteo-odonto-keratoprosthesis (OOKP). Ophthalmic Research 2001; 33: S1, 94
- Green D, Liu C, Tighe B J. Marine products for ophthalmology. Contact Lens & Ant Eye 1998; 21(4)137
- Green D, Lydon F, Tighe B J, Liu C. Marine Inspired Artifical Cornea. Anales Del Instituto Barraquer. (Barc.) 2001; 30: 219–20